Pyrroles
Medchemexpress LLC Atorvastatin sodium | 134523-01-6 | MFCD08458204 | 99.9% | 580.6 g/mol | C33H34FN2NaO5 | 5 MG
Atorvastatin sodium is the sodium salt form of atorvastatin, an orally active HMG-CoA reductase inhibitor used in research to study lipid-lowering and related biological effects. Supplied as a solid or DMSO solution, it is suitable for in vitro and in vivo studies that require a well-characterized, high-purity HMG-CoA reductase inhibitor.
- Sodium salt form of atorvastatin
- Orally active HMG-CoA reductase inhibitor used in lipid-lowering research
- High reported purity (~99.9%) for consistent experimental results
- Available as solid and as DMSO solution formats for dosing flexibility
- Characterized with CAS 134523-01-6 and molecular weight 580.6 g/mol
Aobchem 1-(4-Bromophenyl)-1H-pyrrole-2 5-dione | ≥97% | CAS 13380-67-1 | C10H6BrNO2 | 5g
1-(4-Bromophenyl)-1H-pyrrole-2 5-dione | ≥97% | CAS 13380-67-1 | C10H6BrNO2 | 5g
Aobchem 1-(3-Nitrophenyl)-1H-pyrrole-2 5-dione | ≥97% | CAS 7300-93-8 | C10H6N2O4 | 10g
1-(3-Nitrophenyl)-1H-pyrrole-2 5-dione | ≥97% | CAS 7300-93-8 | C10H6N2O4 | 10g
Aobchem 1-(3-Fluorophenyl)-1H-pyrrole-2 5-dione | ≥95% | CAS 7508-99-8 | C10H6FNO2 | 25g
1-(3-Fluorophenyl)-1H-pyrrole-2 5-dione | ≥95% | CAS 7508-99-8 | C10H6FNO2 | 25g
Medchemexpress LLC Osimertinib | 1421373-65-0 | MFCD27988062 | 5mg
Osimertinib | Purity: 99.90% | MW: 499.61 | 1421373-65-0 | MFCD27988062 | 5mg
Selleck Chemical LLC Osimertinib
Osimertinib (AZD9291) is an oral irreversible and mutant-selective EGFR inhibitor with IC50 of 12 92 11 44 and 493 8 nM for Exon 19 deletion EGFR L858R/T790M EGFR and WT EGFR in LoVo cells respectively Phase 3